Decreased appetite is expected
Noninsulin glucose-lowering agents currently used to treat T2D in the USA include biguanides, sulfonylureas, thiazolidinediones, -glucosidase inhibitors, meglitinides, dipeptidyl peptidase 4 inhibitors (DPP4is), sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide 1 receptor agonists (GLP-1 RAs), GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual agonists, bile acid sequestrants, dopamine-2 agonists, and amylin mimetics [3]
Regarding safety, the overall incidence of AEs was similar between the dose and placebo groups
Customer service answers questions fast and I would get my prescriptions on time
When you eat, your body burns carbs and in periods of fasting, your body burns fats